These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22718320)

  • 1. Anti-angiogenic treatment strategies for the therapy of endometriosis.
    Laschke MW; Menger MD
    Hum Reprod Update; 2012; 18(6):682-702. PubMed ID: 22718320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis as a therapeutic target in endometriosis.
    Djokovic D; Calhaz-Jorge C
    Acta Med Port; 2014; 27(4):489-97. PubMed ID: 25203958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis.
    Liu S; Xin X; Hua T; Shi R; Chi S; Jin Z; Wang H
    PLoS One; 2016; 11(11):e0166658. PubMed ID: 27855197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenesis therapy for endometriosis.
    Nap AW; Griffioen AW; Dunselman GA; Bouma-Ter Steege JC; Thijssen VL; Evers JL; Groothuis PG
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1089-95. PubMed ID: 15001592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models for anti-angiogenic therapy in endometriosis.
    Edwards AK; Nakamura DS; Virani S; Wessels JM; Tayade C
    J Reprod Immunol; 2013 Mar; 97(1):85-94. PubMed ID: 23432875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plants as source of new therapies for endometriosis: a review of preclinical and clinical studies.
    Meresman GF; Götte M; Laschke MW
    Hum Reprod Update; 2021 Feb; 27(2):367-392. PubMed ID: 33124671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic mechanisms of vascularization in endometriosis and their clinical implications.
    Laschke MW; Menger MD
    Hum Reprod Update; 2018 Mar; 24(2):207-224. PubMed ID: 29377994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.
    Novella-Maestre E; Carda C; Noguera I; Ruiz-Saurí A; García-Velasco JA; Simón C; Pellicer A
    Hum Reprod; 2009 May; 24(5):1025-35. PubMed ID: 19189995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic therapies in endometriosis: a systematic review.
    Soares SR; Martínez-Varea A; Hidalgo-Mora JJ; Pellicer A
    Fertil Steril; 2012 Sep; 98(3):529-55. PubMed ID: 22938768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells.
    Sharma I; Dhawan V; Mahajan N; Saha SC; Dhaliwal LK
    Fertil Steril; 2010 Oct; 94(5):1639-46.e1. PubMed ID: 19944411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model.
    Xu H; Lui WT; Chu CY; Ng PS; Wang CC; Rogers MS
    Hum Reprod; 2009 Mar; 24(3):608-18. PubMed ID: 19088106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic drug loaded liposomes: Nanotherapy for early atherosclerotic lesions in mice.
    Pont I; Calatayud-Pascual A; López-Castellano A; Albelda EP; García-España E; Martí-Bonmatí L; Frias JC; Albelda MT
    PLoS One; 2018; 13(1):e0190540. PubMed ID: 29338009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis.
    Mendoza-Torreblanca JG; Cárdenas-Rodríguez N; Carro-Rodríguez J; Contreras-García IJ; Garciadiego-Cázares D; Ortega-Cuellar D; Martínez-López V; Alfaro-Rodríguez A; Evia-Ramírez AN; Ignacio-Mejía I; Vargas-Hernández MA; Bandala C
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and antiangiogenic therapy in endometriosis.
    Becker CM; D'Amato RJ
    Microvasc Res; 2007; 74(2-3):121-30. PubMed ID: 17574280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometriosis management: workflow on genomics and proteomics and future biomolecular pharmacotherapy.
    Tinelli A; Martignago R; Vergara D; Leo G; Malvasi A; Tinelli R
    Curr Med Chem; 2008; 15(21):2099-107. PubMed ID: 18781937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could statins constitute a novel treatment for endometriosis? Systematic review of the literature.
    Gibran L; Maranhão RC; Abrão MS; Baracat EC; Podgaec S
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():153-8. PubMed ID: 24965997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the medical management of endometriosis.
    Panay N
    BJOG; 2008 Jun; 115(7):814-7. PubMed ID: 18485157
    [No Abstract]   [Full Text] [Related]  

  • 19. New medical treatments for endometriosis.
    Olive DL; Lindheim SR; Pritts EA
    Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):319-28. PubMed ID: 15157645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatments for endometriosis.
    Kappou D; Matalliotakis M; Matalliotakis I
    Minerva Ginecol; 2010 Oct; 62(5):415-32. PubMed ID: 20938427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.